US Patent Issued to REGENERON PHARMACEUTICALS on Aug. 5 for "Biologically active molecules, conjugates thereof, and therapeutic uses" (New York Inventor)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,258, issued on Aug. 5, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Biologically active molecules, conjugates thereof, and therapeutic uses" was invented by Thomas Nittoli (Pearl River, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to linker compounds that are useful in covalently linking biologically active molecules with Ligands. The disclosed compounds also relate to biologically active molecules and Ligand conjugates, wherein the biologically active molecule is linked to the Ligand through a linker. The disclosure further provides compositions comprising biologically active molecule-ligan...